Last reviewed · How we verify
NCT05099718
Effect of Hyaluronic Acid on Oral Mucosal Wound Healing - Focus on Pain and Re-epithelisation
NA trial testing palatal soft tissue harvesting in Soft Tissue Wound Healing in 25 participants. Completed in 31 May 2023.
31 May 2023
Quick facts
| Lead sponsor | Malmö University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 10 January 2022 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- palatal soft tissue harvesting
- Hyaluronic acid (HYALURONIC ACID) — full drug profile →
- Saline solution (placebo)
Conditions studied
- Soft Tissue Wound Healing — all drugs for Soft Tissue Wound Healing →
Sponsor
Malmö University
Who can join
Adults 18 to 65, any sex, with Soft Tissue Wound Healing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Establishment of a sufficiently wide and thick keratinized gingival/mucosal tissue cuff around teeth/implants is considered of importance for long-term stability. This can more readily be achieved by means of autogenous soft tissue grafts harvested from the palate than with soft tissue substitutes. However, this often implies the creation of an open palatal wound involving secondary intention healing. The aim of this randomized controlled, split-mouth, clinical trial is to assess the effect of a hyaluronic acid containing commercial product on wound healing and patient morbidity after palatal soft tissue harvesting. Altogether, 20 volunteers will be recruited. An individualized splint containing 2 symmetrically located contralateral cylindrical openings will be used for standardized soft tissue harvesting (6 mm in Ø, 2 mm in depth). Soft tissue grafts will be harvested randomly from the right or left side and patients will be monitored for 3 weeks followed by a 1-month wash-out period prior to harvesting the second soft tissue graft from the other side. Participants will randomly start treating the palatal wound either with the test product (GUM Aftaclear Gel, Sunstar Suisse SA, Etoy, Switzerland; 0.3%) or saline solution for 7 days to promote the healing process, which will be reversed for the second round. Patient-related outcomes (morbidity, discomfort, taste alteration, pain killer consumption), frequency of bleeding events, defect closure (area, volume), and microbial colonisation will be recorded and analysed for any differences between the control and test product. Further, in 6 additional volunteers, biopsies of the healing wound are collected in a similar fashion as described above, but with the use of a larger stent in order to harvest also pristine surrounding tissues for histological analysis; biopsies are collected up to 14 days of healing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05099718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Malmö University trials
Trials by the same sponsor.
- NCT07390019 — Families Experiencing Cancer - Support to Prevent Cancer-related Illness · NA · not yet recruiting
- NCT07344909 — Burning Mouth Syndrome: Effects of Occlusal Splint Therapy · NA · not yet recruiting
- NCT07095101 — ePROPP - eHealth for Preventing and Reducing Orofacial Pain in the Population · NA · not yet recruiting
- NCT07266701 — The General Aim is to Implement Clinical Assessment of Overload by Voluntary Bite Force Registration to Enable Future Si · enrolling by invitation
- NCT06833034 — Comparing a Novel Closed Exposure Technique to a Conventional Method for Palatally Impacted Maxillary Canines · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05099718 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Malmö University
- Last refreshed: 5 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05099718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing